Clinical trial
Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced…
NCT00054886 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00054886 |
|---|---|
| Title | Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer |
| Official title | Phase II Study Of Single-Agent SU011248 In The Second-Line Treatment Of Patients With Metastatic Renal Cell Carcinoma |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Neoplasms |
| Intervention type | Drug |
| Interventions | SU-011, 248 |
| Enrollment | 63 |
| Start date | Jan 1, 2003 |
| Completion | Aug 1, 2004 |
| First posted | Feb 13, 2003 |
| Last update posted | May 7, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: